R. Azarian
R. Azarian publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Internal Medicine, on topics such as Venous Thromboembolism Diagnosis and Management, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment.
- World rank
- #1,691,015 of 7,710,434 ranked researchers
- Rank in France
- #74,918 of 324,115
- Works
- 50
- Citations
- 2.3k
- Citations per work
- 45.8
What does R. Azarian research?
R. Azarian's work is mostly in Medicine (70%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3570.0%
- Medicine3570.0%
- Everything else1530.0%
- 1Pulmonary and Respiratory Medicine28% of their works
- 2Oncology10% of their works
- 3Internal Medicine10% of their works
- 4Infectious Diseases8% of their works
- 5Surgery8% of their works
- 6Epidemiology7% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Pulmonary Hypertension Research and Treatments
- Lung Cancer Research Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
- Neuroendocrine Tumor Research Advances
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe R. Azarian's research?
The keywords of their largest research topics: Treatment Guidelines, Clinical Trials, Targeted Therapy, Diagnosis, Chemotherapy, Treatment, Antithrombotic Therapy and Venous Thromboembolism.
- Pneumonia
- Pancreatic Neuroendocrine Tumors
- Thrombosis
- Small-Cell Lung Cancer
- Right Heart Assessment
- Lung Cancer
- EGFR Mutations
- Venous Thromboembolism
- Treatment
- Diagnosis
- Clinical Trials
- Treatment Guidelines
- Targeted Therapy
- Chemotherapy
- Antithrombotic Therapy
- ALK Inhibitors
- CT Screening
- Pulmonary Hypertension
- Genomic Profiles
- Heparin-Induced Thrombocytopenia
- Neuroendocrine Tumors
- Pneumocystis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Treatment Guidelines222 topics
- Clinical Trials212 topics
- Targeted Therapy212 topics
- Diagnosis203 topics
- Chemotherapy192 topics
- Treatment162 topics
- Antithrombotic Therapy131 topic
- Venous Thromboembolism131 topic
- ALK Inhibitors121 topic
- EGFR Mutations121 topic
- CT Screening101 topic
- Lung Cancer101 topic
- Pulmonary Hypertension101 topic
- Right Heart Assessment101 topic
- Genomic Profiles91 topic
- Small-Cell Lung Cancer91 topic
- Heparin-Induced Thrombocytopenia41 topic
- Thrombosis41 topic
- Neuroendocrine Tumors31 topic
- Pancreatic Neuroendocrine Tumors31 topic
- Pneumocystis31 topic
- Pneumonia31 topic
Where does R. Azarian work?
R. Azarian's main affiliation in the publication record is Centre Hospitalier de Versailles, France.
How many publications and citations does R. Azarian have?
OpenAlex counts 50 works and 2,291 citations for R. Azarian, an h-index of 14, ranking #1,691,015 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about R. Azarian. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.